Norges Bank’s Instil Bio TIL Stock Holding History

Norges Bank’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-750	Closed	-$257K	–	2234
2021 Q4	$257K	Hold	750	–	–	﹤0.01%	2183
2021 Q3	$268K	Hold	750	–	–	﹤0.01%	2251
2021 Q2	$290K	Hold	750	–	–	﹤0.01%	2189
2021 Q1	$376K	Buy	+750	New	+$385K	﹤0.01%	2104

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank's TIL Position: Q1 2022 in Review

Norges Bank sold out of Instil Bio (TIL) in Q1 2022, closing a stake of 750 shares — an estimated $257K sold.

Norges Bank first reported a position in TIL in Q1 2021 and held it in 4 quarters. The position peaked at $376K in Q1 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q1 2022.

Norges Bank reported no remaining Instil Bio position as of Q1 2022 after selling out during the quarter.
Norges Bank sold 750 Instil Bio shares in Q1 2022, an estimated $257K.
Norges Bank first reported a position in Instil Bio in Q1 2021 and held it in 4 quarters.
Norges Bank's Instil Bio position peaked at $376K in Q1 2021.
78 funds tracked by Wall St. Rank held Instil Bio as of Q1 2022.

Based on Norges Bank's 13F filing for Q1 2022, filed 9 May 2022.